THEOFAN GEORGIA 4
4 · IMMUNE RESPONSE CORP · Filed Oct 4, 2004
Insider Transaction Report
Form 4
THEOFAN GEORGIA
VP, Clinical Development
Transactions
- Award
Common Stock
2004-09-30$1.20/sh+2,552$3,062→ 13,027 total
Footnotes (1)
- [F1]Matching company contribution to 401K account.